Literature DB >> 6029941

Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

A Pletscher, G Bartholini, R Tissot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6029941     DOI: 10.1016/0006-8993(67)90154-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  17 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 2.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Observations on the dopaminergic nature of hyperthyroid chorea.

Authors:  H L Klawans; D M Shenker
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

Authors:  D Eccleston; G W Ashcroft; T B Crawford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

Review 5.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

6.  The incorporation of 51Cr-3, 4-dihydroxyphenylalanine (DOPA) complex into melanoma B 16.

Authors:  L J Anghileri; E S Miller
Journal:  Z Krebsforsch       Date:  1970-11-20

7.  On the occurence of vanillic acid in human brain and cerebrospinal fluid.

Authors:  G Ebinger; R Verheyden
Journal:  J Neurol       Date:  1976-04-23       Impact factor: 4.849

8.  The metabolism of orally administered L-Dopa in Parkinsonism.

Authors:  D B Calne; F Karoum; C R Ruthven; M Sandler
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

9.  L-dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration).

Authors:  H L Klawans; E Zeitlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

10.  Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus.

Authors:  S C Gopal; A Pandey; I Das; A N Gangopadhyay; V D Upadhyaya; J P N Chansuria; T B Singh
Journal:  Childs Nerv Syst       Date:  2007-12-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.